Pitfalls of using polymerase chain reaction-based assays for JAK2 and CALR exon 9 variant testing in myeloproliferative neoplasms: Knowing when to go the extra mile!
CONCLUSIONS: These cases highlight the importance of understanding the pitfalls of molecular techniques in current practice.PMID:37788380 | DOI:10.1093/ajcp/aqad122
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Kritika Krishnamurthy Jiani Chai Yanhua Wang Rizwan Naeem D Yitzchak Goldstein Source Type: research
More News: Myeloproliferative Disorders | Pathology